These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34899684)

  • 1. Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response.
    Song J; Tang Y; Luo X; Shi X; Song F; Ran L
    Front Immunol; 2021; 12():715508. PubMed ID: 34899684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma.
    Tang W; Shi Z; Zhu Y; Shan Z; Jiang A; Wang A; Chen M; Bao Y; Ju G; Xu W; Wang J
    Sci Rep; 2023 Jul; 13(1):11668. PubMed ID: 37468683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
    Mo Z; Li P; Cao Z; Zhang S
    Front Immunol; 2021; 12():564948. PubMed ID: 34290693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
    Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer.
    Huang K; Hu M; Chen J; Wei J; Qin J; Lin S; Du H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response.
    Zheng H; Wang G; Wang Y; Liu J; Ma G; Du J
    iScience; 2023 Oct; 26(10):108055. PubMed ID: 37854704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive pan-cancer analysis reveals SIRT5 is a predictive biomarker for prognosis and immunotherapy response.
    Ji Y; Li C; Wan S; Zhang K; Liu Y; Shi S
    Funct Integr Genomics; 2024 Mar; 24(2):60. PubMed ID: 38499806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
    Tian M; Yang J; Han J; He J; Liao W
    Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring
    Wang Q; Yang Y; Yang M; Li X; Chen K
    Aging (Albany NY); 2020 Jun; 12(11):10827-10843. PubMed ID: 32491995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis.
    Zhao Y; Wu J; Li L; Zhang H; Zhang H; Li J; Zhong H; Lei T; Jin Y; Xu B; Song Q
    Front Genet; 2022; 13():820135. PubMed ID: 35222540
    [No Abstract]   [Full Text] [Related]  

  • 14. CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis.
    Wang L; Liu Z; Liu L; Guo C; Jiao D; Li L; Zhao J; Han X; Sun Y
    J Cell Mol Med; 2021 Aug; 25(15):7559-7574. PubMed ID: 34288370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of ion channel genes predicts clinical outcome in breast cancer.
    Ko JH; Ko EA; Gu W; Lim I; Bang H; Zhou T
    Mol Cancer; 2013 Sep; 12(1):106. PubMed ID: 24053408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
    Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
    J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer analysis reveals that neurotrophin signaling correlates positively with anti-tumor immunity, clinical outcomes, and response to targeted therapies and immunotherapies in cancer.
    Feng Q; Song D; Wang X
    Life Sci; 2021 Oct; 282():119848. PubMed ID: 34293398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
    Yu Y; Zhang W; Li A; Chen Y; Ou Q; He Z; Zhang Y; Liu R; Yao H; Song E
    JAMA Netw Open; 2020 Apr; 3(4):e202149. PubMed ID: 32259264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.